Literature DB >> 7835872

Effects of maternal smoking on adverse pregnancy outcomes: examination of the criteria of causation.

R A Walsh1.   

Abstract

Smoking during pregnancy has been associated with many adverse pregnancy outcomes. However, debate continues about whether smoking causes these outcomes. This review of the criteria of causation found that the relative risk of having a low-birth-weight baby is nearly doubled in women who smoke during pregnancy compared with nonsmoking women and that the relative risks of spontaneous abortion and perinatal and neonatal mortality are increased by about one-third. The magnitude of the long-term effects of maternal smoking on the physical and mental development of the offspring is small but measurable. The epidemiologic evidence associating maternal smoking with major adverse pregnancy outcomes in prospective and case-control studies displays a high degree of consistency. A dose-response gradient for smoking during pregnancy has not been clearly shown in relation to perinatal and neonatal mortality. However, there is strong support for a dose-response gradient in relation to low birth weight and spontaneous abortion and moderate support for long-term developmental effects. Although a biological causal mechanism has not been clearly delineated, considerable evidence indicates that the chemicals in tobacco smoke are capable of producing deleterious changes in the placenta and fetus.

Entities:  

Mesh:

Year:  1994        PMID: 7835872

Source DB:  PubMed          Journal:  Hum Biol        ISSN: 0018-7143            Impact factor:   0.553


  48 in total

1.  Coverage of tobacco dependence treatments for pregnant smokers in health maintenance organizations.

Authors:  K E Pickett; B Abrams; H H Schauffler; J Savage; P Brandt; A Kalkbrenner; S A Chapman
Journal:  Am J Public Health       Date:  2001-09       Impact factor: 9.308

2.  Maternal smoking during pregnancy and severe antisocial behavior in offspring: a review.

Authors:  Lauren S Wakschlag; Kate E Pickett; Edwin Cook; Neal L Benowitz; Bennett L Leventhal
Journal:  Am J Public Health       Date:  2002-06       Impact factor: 9.308

Review 3.  Does smoking by pregnant women influence IQ, birth weight, and developmental disabilities in their infants? A methodological review and multivariate analysis.

Authors:  M C Ramsay; C R Reynolds
Journal:  Neuropsychol Rev       Date:  2000-03       Impact factor: 7.444

4.  A method to guide community planning and evaluation efforts in tobacco control using data on smoking during pregnancy.

Authors:  V H Newburn; P L Remington; P E Peppard
Journal:  Tob Control       Date:  2003-06       Impact factor: 7.552

5.  Smoking cessation counseling with pregnant and postpartum women: a survey of community health center providers.

Authors:  J G Zapka; L Pbert; A M Stoddard; J K Ockene; K V Goins; D Bonollo
Journal:  Am J Public Health       Date:  2000-01       Impact factor: 9.308

Review 6.  Biomarkers to assess the utility of potential reduced exposure tobacco products.

Authors:  Dorothy K Hatsukami; Neal L Benowitz; Stephen I Rennard; Cheryl Oncken; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2006-08       Impact factor: 4.244

7.  Maternal smoking during pregnancy and birthweight: a propensity score matching approach.

Authors:  Paula Veloso da Veiga; Ronald P Wilder
Journal:  Matern Child Health J       Date:  2007-06-06

8.  A smoking cessation program at a public antenatal clinic.

Authors:  R A Walsh; S Redman; M W Brinsmead; J M Byrne; A Melmeth
Journal:  Am J Public Health       Date:  1997-07       Impact factor: 9.308

9.  The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development.

Authors:  J Elliott Scott
Journal:  Tob Induc Dis       Date:  2004-03-15       Impact factor: 2.600

10.  Calibrating self-reported measures of maternal smoking in pregnancy via bioassays using a Monte Carlo approach.

Authors:  Vanja M Dukic; Marina Niessner; Kate E Pickett; Neal L Benowitz; Lauren S Wakschlag
Journal:  Int J Environ Res Public Health       Date:  2009-06-03       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.